Pfizer says acquiring biotech firm Medivation for $14 billion

Pfizer says acquiring biotech firm Medivation for billion
Zee Business
Pfizer will purchase biotech firm Medivation, which specializes in cancer treatments, for some $14 billion, the US pharma giant said in a statement on Monday.

It's only fair to share...Share on Facebook0Share on Google+0Tweet about this on TwitterShare on LinkedIn0